Arcaini et al developed a prognostic model for patients with splenic marginal zone lymphoma. This can help identify patients who may benefit from more aggressive management. The authors are members of the Intergruppo Italiano Linfomi representing multiple oncology centers in Italy.
Parameters:
(1) hemoglobin in g/dL
(2) serum LDH
(3) serum albumin
Parameter |
Finding |
Points |
hemoglobin |
>= 12.0 g/dL |
0 |
|
< 12.0 g/dL |
1 |
serum LDH |
<= upper limit of normal |
0 |
|
> upper limit of normal |
1 |
serum albumin |
>= 3.5 g/dL |
0 |
|
< 3.5 g/dL |
1 |
total score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 3
• The higher the score the worse the prognosis.
Total Score |
Risk Group |
5 Year Cause Specific Survival |
0 |
low |
88% |
1 |
intermediate |
73% |
2 or 3 |
high |
50% |
Specialty: Hematology Oncology